<DOC>
	<DOCNO>NCT00491387</DOCNO>
	<brief_summary>This study patient high blood pressure already treat angiotensin convert enzyme inhibitor receptor blocker achieve good fair blood pressure control . The hypothesis addition beta-adrenergic receptor blocker , sustained-release metoprolol , provide additional blockade sympathetic nervous system , thereby improve leave ventricular fill blood pressure control .</brief_summary>
	<brief_title>Sympathetic Nervous System Modulation Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Essential hypertension blood pressure le 140/90 either ACE inhibitor angiotensin receptor blocker Known valvular heart disease mild severity Known coronary artery disease define angiographic coronary artery stenosis great equal 50 % luminal diameter narrowing , acute previous myocardial infarction , previous coronary revascularization Known nonischemic cardiomyopathy leave ventricular ejection fraction le 50 % Atrial fibrillation Current treatment Î²adrenergic block drug calcium channel blocker Current treatment psychoactive drug know alter 123IMIBG uptake Participation another research study within prior 30 day A lifelimiting disease process likely preclude completion study participation Pregnancy breast feed Inability unwillingness provide inform consent Baseline rest heart rate le 65 beat per minute Diabetes Iodine allergy Unwilling sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>sympathetic nervous system</keyword>
</DOC>